Showing results (1-10 of 42) with videos related to
Sort By:
Pageof 5
Cancer Cell|February 14, 2023
Paradoxical cancer cell stimulation by IFNγ drives tumor hyperprogression upon checkpoint blockade immunotherapyStephane Champiat, Aurelien MarabelleCurrent Opinion in Oncology|January 21, 2015
Immune checkpoint inhibitors in advanced nonsmall cell lung cancerCarole Helissey, Stephane Champiat, Jean-Charles SoriaNature Reviews. Clinical Oncology|May 19, 2021
Intratumoural administration and tumour tissue targeting of cancer immunotherapiesIgnacio Melero, Eduardo Castanon, Maite Alvarez, et al.Journal for Immunotherapy of Cancer|September 24, 2025
Immune-related adverse events occurring rapidly after a single dose of immune checkpoint blockadeRomain Guitton, Ariane Laparra, Noemie Chanson, et al.European Journal of Cancer (Oxford, England : 1990)|April 2, 2025
Radiomic markers associated with clinical benefit in patients with radiographic progression of advanced uveal melanoma on tebentafuspVolkan Beylergil, Laura Collins, Lawrence H Schwartz, et al.Journal for Immunotherapy of Cancer|May 3, 2024
Phase 1 first-in-human dose-escalation study of ANV419 in patients with relapsed/refractory advanced solid tumorsLaurent Mathiot, David Combarel, Justin Cagnat, et al.Clinical and Vaccine Immunology : CVI|July 3, 2009
Transcriptional errors in human immunodeficiency virus type 1 generate targets for T-cell responsesKeith E Garrison, Stephane Champiat, Vanessa A York, et al.NPJ Precision Oncology|June 12, 2026
Genomic co-alterations and immune-related adverse events shape outcomes of thymic malignancies treated with immune checkpoint inhibitorsHarold Nathan Tan, Hung Le, Khaoula Ben Haj Frej, et al.Frontiers in Oncology|May 31, 2021
Role of Cardiac Imaging in the Diagnosis of Immune Checkpoints Inhibitors Related MyocarditisStéphane Ederhy, Joe-Elie Salem, Laurent Dercle, et al.Expert Review of Anticancer Therapy|July 11, 2022
Immunosenescence, inflammaging, and cancer immunotherapy efficacyJulieta E Rodriguez, Marie Naigeon, Vincent Goldschmidt, et al.Pageof 5